Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxalidine fumarate injection for comfortable outpatient painless gastroscopy
ChiCTR2500102025Phase 4Recruiting
- Sponsor
- Xianyang Central Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in procedural discomfort (3 arms), sponsored by Xianyang Central Hospital. Primary endpoint: Incidence of respiratory depression. Started May 2025; status: recruiting.
02
Drugs
oliceridine
03
Conditions
procedural discomfort
Beyond the preview
Go deeper on ChiCTR2500102025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102025.